The study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with or without eosinophilic duodenitis (EoD). Participants with EoD only are not eligible for enrollment. EoG and EoD are u...
- Gastritis
- Gastrointestinal Diseases
- Digestive System Diseases
- Eosinophilic Esophagitis
- Enteritis
- Duodenitis
- Eosinophilia
Age: 12 years - 66+
Gender: All